摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3H-1,4,8B-三氮杂苊烯e-3,5(4H)-二酮 | 177485-64-2

中文名称
3H-1,4,8B-三氮杂苊烯e-3,5(4H)-二酮
中文别名
2,4,6(1H,3H,5H)-嘧啶三酮,1,3-二甲基-5-(1,2,3,4-四氢-1,3-二甲基-2,4-二羰基-7H-环庚三烯并[4,5]呋喃并[2,3-d]嘧啶-7-亚基)-
英文名称
4,5-Dihydro-3H-1,4,8b-triazaacenaphthylene-3,5-dione
英文别名
3H-1,4,8b-Triazaacenaphthylene-3,5(4H)-dione;2,6,12-triazatricyclo[6.3.1.04,12]dodeca-1,3,8,10-tetraene-5,7-dione
3H-1,4,8B-三氮杂苊烯e-3,5(4H)-二酮化学式
CAS
177485-64-2
化学式
C9H5N3O2
mdl
——
分子量
187.158
InChiKey
IBLXHGHUMZWKRK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    63.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE<br/>[FR] COMPOSES TRICYCLIQUES, LEUR PRODUCTION ET UTILISATION
    申请人:TAKEDA CHEMICAL INDUSTRIES, LTD.
    公开号:WO1996002542A1
    公开(公告)日:1996-02-01
    (EN) Tricyclic compound of formula (I'), wherein ring A is a nitrogen-containing heterocyclic ring, having two nitrogen atoms as the hetero-atoms, which is optionally substituted with oxo or thioxo; ring Q may optionally be substituted; Y is an optionally substituted hydrocarbon group, an optionally substituted hydroxyl group or an optionally substituted mecapto group, excluding for methyl group as Y; R1 is a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group or an acyl group, or a salt thereof, having excellent PDGF-inhibiting activities, antihypertensive activities, activities of ameliorating renal diseases and activities of lowering lipil level.(FR) L'invention se rapporte à un composé tricyclique de la formule (I') dans laquelle le noyau A est un noyau hétérocyclique contenant de l'azote, et possédant deux atomes d'azote comme hétéro-atomes, et qui est éventuellement substitué par oxo ou thio; le noyau Q peut être éventuellement substitué; Y est un groupe hdyrocarbure éventuellement substitué, un groupe hdyroxyle éventuellement substitué ou un groupe mercapto éventuellement substitué, à l'exclusion d'un groupe méthyle; R1 est un atome d'hydrogène, un atome d'halogène, un groupe hydrocarbure éventuellement substituté ou un groupe acyle, ou un sel de celui-ci. Ce composé présente d'excellentes activités inhibant PDGF (facteur de croissance plaquettaire), des activités anti-hypertensives, des activités apportant une amélioration aux maladies rénales et des activités favorisant la réduction du taux lipidique.
    (I')式的三环化合物,其中环A是一个含氮杂环,具有两个氮原子作为杂原子,可以用氧代或代取代;环Q可以选择性地被取代;Y是一个可选择性取代的碳氢基团、可选择性取代的羟基团或可选择性取代的巯基团,不包括甲基基团作为Y;R1是一个氢原子、卤素原子、可选择性取代的碳氢基团或酰基,或其盐,具有出色的PDGF抑制活性、降压活性、改善肾脏疾病活性和降低脂质平的活性。
  • Tricyclic compounds, their production and use
    申请人:——
    公开号:US20010051631A1
    公开(公告)日:2001-12-13
    Tricyclic compound of the formula: 1 wherein ring A is a nitrogen-containing heterocyclic ring, having two nitrogen atoms as the hetero-atoms, which is optionally substituted with oxo or thioxo; ring Q may optionally be substituted; Y is an optionally substituted hydrocarbon group, an optionally substituted hydroxyl group or an optionally substituted mecapto group, excluding for methyl group as Y; R 1 is a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group or an acyl group, or a salt thereof, having excellent PDGF-inhibiting activities, antihypertensive activities, activities of ameliorating renal diseases and activities of lowering lipid level.
    式子1中的三环化合物:其中环A是含有两个氮原子作为杂原子的含氮杂环,可选择性地用氧代或代取代; 环Q可以选择性地被取代; Y是可选择性取代的碳氢基团,可选择性取代的羟基或可选择性取代的巯基,但不包括甲基基团作为Y; R1是氢原子,卤素原子,可选择性取代的碳氢基团或酰基,或其盐,具有优异的PDGF抑制活性,降压活性,改善肾脏疾病活性和降低脂质平活性。
  • US05958942
    申请人:——
    公开号:——
    公开(公告)日:——
  • TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0771319A1
    公开(公告)日:1997-05-07
  • US5958942A
    申请人:——
    公开号:US5958942A
    公开(公告)日:1999-09-28
查看更多

同类化合物

3H-1,4,8B-三氮杂苊烯e-3,5(4H)-二酮 2,3,4,5-tetrahydro-1H-pyrido[2',1':2,3]imidazo[4,5-c]azepin-1-one ethyl 2-acetyl-3-(2-hydroxy-6,8-dimethylimidazo[1,2-a]pyridin-3-yl)-3-(methylthio)acrylate 6-ethyl-8-methylpyrido[1,2-a]benzimidazole (7S,8R)-8-amino-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-3-carbonitrile 7-methoxy-1-(3-propynyl)-1,2,3,4-tetrahydropyrido<3',2':4,5>imidazo<1,2-a>pyrimidin-2-one (7R,8S)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine 2,4-dimethyl-7,8,9,10-tetrahydro-pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine (7R,8S)-4-fluoro-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine 1,3-Dihydro-2-methyl-4-methylthio-3-oxo-2H-2,5-diazacyclo<3.2.3>azin 3-(6-{[(3R,5S)-5-(methoxymethyl)pyrrolidin-3-yl]amino}pyrazin-2-yl)imidazo[1,2-a]pyridine-7-carbonitrile 7-hydroxy-3-propylimidazo[1,2-a]pyridine-8-carbonitrile 6-Methyl-9-oxa-1,4a-diaza-fluoren-2-one 8-nitro-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-3-carbonitrile 2,3-dichloro-7-trichloromethyl-imidazo[1,2-a]pyridine Ethyl 4-thiophen-2-ylquinolizin-5-ium-1-carboxylate;bromide 2-methyl-1H-cyclopenta[4,5]imidazo[1,2-a]pyridin-3(2H)-one 2-ethoxycarbonyl-3-oxo-2,3-dihydro-thiazolo[3,2-a]pyridinylium betaine 14a-methyl-9-(pyridin-2-ylethynyl)-2,3,5,6,14,14a-hexahydropyrrolo[2',1':3,4][1,4]diazepino[7,1-b]quinazolin-12(1H)-one 2,9-dimethyl-benzo[1'',2'':4,5;4'',5'':4',5']diimidazo[1,2-a;1',2'-a]dipyridine-6,13-dione 8,9-dihydrobenzo[4,5]imidazo[1,2-a]pyridin-6(7H)-one 6,7-dimethyl-9-propylimidazo[1,5-a]pyrido[3,2-e]pyrazin-2(1H)-one 2-acetyl-4,5-dihydropyrrolo[4,5-g]pyrido[1,2-a]benzimidazole 8-hydroxymethylene-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]benzimidazol-9-one 10-Benzyl-13-propan-2-yl-2,8,11,14-tetrazatricyclo[7.5.0.02,7]tetradeca-1(9),3,5,7-tetraen-12-one 2-fluoro-6,9-dimethylpyrido[1,2-a]benzimidazole dipyrido[1,2-a:1',2'-a']benzo[1,2-d:5,4-d]diimidazole-6,13-dione 3-Aethoxycarbonyl-2-amino-1,4-dihydro-8a-aza-acridon 3-bromo-8-chloro-11-[(1-methyl)piperidin-4-yl]-5H,11H-pyrrolo[2,1-c][1,4]benzoxazepine N-((4aR,11bR)-2-amino-3,3,11b-trimethyl-4,4-dioxido-3,4a,5,6,7,11b-hexahydrobenzo[3,4]cyclohepta[1,2-b][1,4]thiazin-10-yl)-6-chloro-3-methylimidazo[1,2-a]pyridine-2-carboxamide 1,3-difluoro-4,9-dimethyl-dipyrido[1,2-a;3',4'-d]imidazole 5-((2-(dimethylamino)ethoxy)imino)pyrido[1',2':1,2]imidazo[4,5-f]isoquinolin-6(5H)-one Dipyrido<1.2-a;1'.2'-c>imidazolium-(10)-bromid 8-(trifluoromethyl)-2,3,4,5-tetrahydro-1H-pyrido[1',2':1,2]imidazo[4,5-d]azepine 3,4-difluoro-1-methoxy-9-methyl-dipyrido[1,2-a;3',4'-d]imidazole benzo[4,5]imidazo[1,2-a]pyridin-6-ylmethanol (7R,8S)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridin-8-amine 7-(4-ethyl-1,4-diazepan-1-yl)-3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)-2H-pyrano[2,3-b]pyridin-2-one 2-tert-butyl-8-oxo-7,9-dimethylimidazo<4.5-c>imidazo<1.2-a>pyridine 8-amino-7-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile 2,8,12-Triazatricyclo[7.5.0.02,7]tetradeca-1(9),3,5,7-tetraene 2-ethylpyrido<1'',2'':1',2'>imidazo<4',5':4,5>imidazo<1,2-c>pyrimidin-1-one 3,4-bis(hydroxymethyl)dipyrido[1,2-a;3',4'-d]imidazole 3-methyldipyrido[1,2-a;3',4'-d]imidazole 2-methyl-6,7,8,9-tetrahydropyrido<1,2-a>benzimidazole 6,7,8,9-tetrahydrobenzo[4,5] imidazo[1,2-a]pyridin-3-amine 3-bromo-6,7,8,9-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine N-[1-[3-(3-cyanophenyloxy)propan-1-yl]piperidin-4-yl]-5-thia-1,8b-diazaacenaphthylene-4-carboxamide N-[1-[3-(2-cyanophenyloxy)propan-1-yl]piperidin-4-yl]-5-thia-1,8b-diazaacenaphthylene-4-carboxamide